Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ectopy Triggering Ganglionated Plexus Ablation to Prevent Atrial Fibrillation
Sponsor: Imperial College London
Summary
Atrial fibrillation (AF) is a common heart rhythm disorder which can significantly affect a patient's quality of life and cause strokes. Abnormal electrical activity from the pulmonary veins are thought to be the most common cause of this condition. Current ablative strategy in drug refractory AF is pulmonary vein isolation (PVI), where the pulmonary veins are electrically isolated from the body of the left atrium. However, success rate of this procedure remain \~50-70% for a single procedure despite advances in mapping and ablation techniques. Ganglionated plexuses (GP) are dense clusters of nerves in the atria that are implicated in AF. Endocardial high frequency stimulation (HFS) delivered within the local atrial refractory period can trigger ectopy and AF from specific GP sites (ET-GP). The aim of this study was to understand the role of ET-GP ablation in the treatment of AF by comparing two different strategies: 1. Pulmonary vein isolation alone 2. GP ablation alone
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
116
Start Date
2017-12-01
Completion Date
2024-10-23
Last Updated
2024-09-23
Healthy Volunteers
No
Conditions
Interventions
Pulmonary vein isolation
Conventional endocardial radiofrequency catheter ablation for pulmonary vein isolation.
Ganglionated plexus ablation
Endocardial radiofrequency catheter ablation of ganglionated plexus in the left atrium
Locations (3)
Hammersmith Hospital
London, United Kingdom
St Bartholomew's Hospital
London, United Kingdom
Derriford Hospital
Plymouth, United Kingdom